Le Lézard
Classified in: Covid-19 virus
Subjects: Event, Webcast

Magellan Healthcare Hosts Webinars in Support of National Depression and Mental Health Awareness and Screening Month


Magellan Healthcare, the behavioral and specialty healthcare segment of Magellan Health, Inc. (NASDAQ: MGLN), offers resources for youth and adults in support of National Depression and Mental Health Awareness and Screening Month in October.

Increased stressors brought about by the pandemic ? grief and loss, social isolation, financial instability, fear, etc. ? have exacerbated the state of mental health in the U.S. and increased the number of people looking for assistance. From January to September 2020, individuals who self-screened for anxiety increased by 93%, compared to all of 2019, and depression screening increased by 62% over the same time.1 Since COVID-19 began, suicidal ideation in the U.S. has more than doubled, with younger adults, racial/ethnic minorities, essential workers, and unpaid adult caregivers experiencing disproportionately worse effects.2

Among those who experience a mental health illness, more than half do not receive treatment.3 Magellan Healthcare research has found that 60% of first-time behavioral health emergency department visits are the result of patients who saw their primary care physician within the previous six months yet had no behavioral health diagnosis.

"With historic spikes in depression and anxiety, the need for mental health screening as part of comprehensive behavioral healthcare is becoming more critical by the day," said Candice Tate, M.D., medical director, Magellan Healthcare. "It is also increasingly difficult for individuals to access the necessary care due to provider shortages and limited access in rural areas. During National Depression and Mental Health Awareness and Screening Month, Magellan Healthcare is pleased to share resources to help individuals and primary care providers identify and address depression and other mental health conditions before they escalate."

During October, Magellan will host the following virtual events focused on depression and mental health for adults and youth:

Additional Magellan Mental Health Support Resources

Magellan Healthcare has additional resources available to all individuals, especially those who may be feeling stress or anxiety:

About Magellan Healthcare: Magellan Healthcare, Inc. the healthcare business unit of Magellan Health, Inc., offers solutions for complex conditions in the areas of behavioral health and medical specialty treatment. Magellan Healthcare serves commercial health plans, employers, state and local governments, and the Federal government, including the Department of Defense. For more information, visit MagellanHealthcare.com.

About Magellan Health: Magellan Health, Inc. is a leader in managing the fastest growing, most complex areas of health, including special populations, complete pharmacy benefits and other specialty areas of healthcare. Magellan supports innovative ways of accessing better health through technology, while remaining focused on the critical personal relationships that are necessary to achieve a healthy, vibrant life. Magellan's customers include health plans and other managed care organizations, employers, labor unions, various military and governmental agencies and third-party administrators. For more information, visit MagellanHealth.com.

(MGLN-GEN)

1 https://mhanational.org/issues/state-mental-health-america

2 https://www.cdc.gov/mmwr/volumes/69/wr/mm6932a1.htm

3 https://www.samhsa.gov/data/sites/default/files/reports/rpt29392/Assistant-Secretary-nsduh2019_presentation/Assistant-Secretary-nsduh2019_presentation.pdf (slide #52)


These press releases may also interest you

at 05:00
The "Immunoassay Markets. Strategies and Trends. Forecasts by Application, Technology, Product, User and by Country. With Executive Guides, Customized Forecasting and Analysis. 2023 to 2027" report has been added to ResearchAndMarkets.com's offering....

at 00:25
Shanghai Junshi Biosciences Co., Ltd ("Junshi Biosciences," HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of novel therapies, announced its financial...

28 mar 2024
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

28 mar 2024
Discovery Silver Corp. ("Discovery" or the "Company") today announced financial results for the three and twelve months ended December 31, 2023 ("Q4 2023" and "2023", respectively). The Company also provided a summary of key events since the...

28 mar 2024
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

28 mar 2024
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...



News published on and distributed by: